Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Int J Risk Saf Med ; 33(1): 23-26, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-33967060

RESUMEN

BACKGROUND: Pheniramine abuse is reported not only in patients with psychiatric disorders but also in the general population. CASE REPORT: We report a case of pheniramine dependence in a patient with obsessive-compulsive disorder. The patient took about 250 mg orally daily and injected about 90 mg every week from the last six months. It reduced his anxiety, was cheaper than his other psychiatric medications, and free of stigma. He had lethargy, headache, uneasiness, anxiety, and poor sleep as withdrawal symptoms. RESULTS: This case highlights the vulnerability of those with psychiatric disorders towards pheniramine abuse. Hence, this report advocates the strict evaluation of over-the-counter drugs for patients with pre-existing psychiatric disorders.


Asunto(s)
Trastorno Obsesivo Compulsivo , Síndrome de Abstinencia a Sustancias , Ansiedad , Trastornos de Ansiedad/inducido químicamente , Trastornos de Ansiedad/diagnóstico , Humanos , Trastorno Obsesivo Compulsivo/diagnóstico , Trastorno Obsesivo Compulsivo/tratamiento farmacológico , Trastorno Obsesivo Compulsivo/epidemiología , Feniramina/efectos adversos
2.
Dermatol Online J ; 24(6)2018 08 23.
Artículo en Inglés | MEDLINE | ID: mdl-30142724

RESUMEN

Fixed drug eruption is a delayed type hypersensitivity reaction to a drug seen most frequently with antibiotics such as tetracyclines, sulfonamides, and NSAIDs such as naproxen and ibuprofen. Although H1-antihistamines rarely elicit cutaneous adverse effects, there have been a few reports in the literature implicating them in causing fixed drug eruption, particularly the piperazine derivatives (hydroxyzine, cetirizine, levocetirizine), and loratadine. However, cutaneous drug reactions with the alkylamine derivatives like pheniramine maleate are extremely uncommon and fixed drug eruptions have not been reported with any of the alkylamine antihistamines to date. We herein report a case of multifocal bullous fixed drug eruption following ingestion of pheniramine maleate.


Asunto(s)
Erupciones por Medicamentos/etiología , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Feniramina/efectos adversos , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/inducido químicamente , Adulto , Erupciones por Medicamentos/tratamiento farmacológico , Erupciones por Medicamentos/patología , Femenino , Glucocorticoides/administración & dosificación , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Feniramina/uso terapéutico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/patología
4.
Int Ophthalmol ; 38(4): 1775-1778, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28669099

RESUMEN

Most of the rare bilateral acute angle closure (AAC) cases are precipitated by systemic factors, such as drug intake, snake bite or general anaesthesia. We present a case of simultaneous bilateral AAC in a middle-aged male, precipitated by the use of medication for flu, containing an alpha-1 adrenergic receptor agonist and an anticholinergic agent. In our case, axial length was shorter, anterior chamber depth was narrower, and the lens was thicker than normal, including the patient within the risk group for AAC. In this circumstance, drugs acted as triggers. Case description and evolution following treatment are completed with the discussion of mechanisms involved in triggering bilateral AAC in predisposed patients, as emerging from literature. This case report brings up the risk of bilateral AAC in patients at risk, of which ophthalmologists, physicians of other specialties and patients should be aware of.


Asunto(s)
Acetaminofén/efectos adversos , Agonistas de Receptores Adrenérgicos alfa 1/efectos adversos , Antagonistas Colinérgicos/efectos adversos , Glaucoma de Ángulo Cerrado/inducido químicamente , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Feniramina/efectos adversos , Fenilefrina/efectos adversos , Humanos , Masculino , Persona de Mediana Edad
5.
Int J Risk Saf Med ; 27(3): 153-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26410249

RESUMEN

Excessive use of over-the-counter (OTC) medications has been a growing public health problem. We present the case of a patient with avoidant personality disorder, social phobia, and dull normal intelligence, with dependence to pheniramine maleate. His anxiety symptoms, initially unresponsive to conventional treatment, reduced only after stopping pheniramine during inpatient care. This case emphasizes the need for awareness and regular monitoring of the use of OTC medications in vulnerable patient populations.


Asunto(s)
Trastornos de la Personalidad/complicaciones , Trastornos de la Personalidad/fisiopatología , Feniramina/administración & dosificación , Feniramina/efectos adversos , Trastornos Relacionados con Sustancias/etiología , Adulto , Humanos , Masculino
9.
Subst Abus ; 26(1): 45-7, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16492663

RESUMEN

Abuse and addiction of histaminergic agonists and antagonists were investigated. The withdrawal signs may become after using drugs such as L-histidine, histamine-N-methyl, promethazine, pheniramine, astemizole, etc. Some medicines which include these active metabolites could lead to dependence cause different side effects. This case suggests that pheniramine abuse also could to dependence. We should pay attention to trend of pheniramine and other histaminergic drugs dependence and need to regulate the market by law more severely.


Asunto(s)
Antialérgicos , Antagonistas de los Receptores Histamínicos H1 , Feniramina , Trastornos Relacionados con Sustancias/diagnóstico , Adulto , Antialérgicos/administración & dosificación , Antialérgicos/efectos adversos , Relación Dosis-Respuesta a Droga , Femenino , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Humanos , Feniramina/administración & dosificación , Feniramina/efectos adversos , Automedicación , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico , Trastornos del Inicio y del Mantenimiento del Sueño/psicología , Síndrome de Abstinencia a Sustancias/diagnóstico , Síndrome de Abstinencia a Sustancias/psicología , Trastornos Relacionados con Sustancias/psicología
11.
Aviat Space Environ Med ; 68(11): 1035-7, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9383505

RESUMEN

The use of topical ocular antihistamine/decongestant combinations to treat symptoms associated with allergic conjunctivitis is widespread, effective, and generally without adverse effects. Recently, these medications have become available without a prescription, possibly leading patients to the erroneous assumption that they are void of side effects. Likewise, patients may use these drugs for many ocular therapies for which they are unintended, possibly resulting in ocular complications. One significant adverse effect of these antihistamine/decongestant combinations when used inappropriately is pupillary dilation with associated blurry vision. Continued emphasis of the possible deleterious side effects by the clinician is recommended to circumvent these problems.


Asunto(s)
Conjuntivitis Alérgica/tratamiento farmacológico , Lentes de Contacto Hidrofílicos/efectos adversos , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Midriasis/inducido químicamente , Nafazolina/efectos adversos , Descongestionantes Nasales/efectos adversos , Medicamentos sin Prescripción/efectos adversos , Feniramina/efectos adversos , Adulto , Combinación de Medicamentos , Humanos , Masculino , Soluciones Oftálmicas
12.
Drugs Exp Clin Res ; 17(8): 399-403, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1688044

RESUMEN

A controlled and completely randomized study was carried out with the aim of assessing the efficacy and safety of oxatomide gel in comparison with another preparation for topical use, dechlorpheniramine. Twenty-seven patients (sixteen F, eleven M) aged between 21 and 72 years (mean age 39) suffering from chronic idiopathic urticaria were treated for 15 days with oxatomide gel at 5% or dechlorpheniramine cream at 1%; 15 days of follow-up without therapy were then observed. Both the treatments allowed significant control of cutaneous symptoms. In particular, in the group treated with oxatomide there was a more marked reduction in itching and in the number of weals (p less than 0.01 between times), and in the dechlorpheniramine group in the severity of erythema (p less than 0.01 between times). During the follow-up period, a distinct flare-up of symptoms was observed only in the dechlorpheniramine group. Acceptability and safety, both clinical and biological, were good for both products.


Asunto(s)
Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Feniramina/administración & dosificación , Piperazinas/administración & dosificación , Urticaria/tratamiento farmacológico , Administración Tópica , Adulto , Anciano , Eritema/tratamiento farmacológico , Femenino , Geles , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Pomadas , Feniramina/efectos adversos , Piperazinas/efectos adversos , Prurito/tratamiento farmacológico , Urticaria/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA